What does Cabinet Médical MEURENS-GROSCH do?

Cabinet Médical MEURENS-GROSCH is a general practice in Olne. Private Limited, started on 23 March 2005.

What is the address of Cabinet Médical MEURENS-GROSCH?

The registered office of Cabinet Médical MEURENS-GROSCH is located at Herdavoie 42, 4877 Olne.

Is Cabinet Médical MEURENS-GROSCH still active?

Yes. According to the CBE (30 September 2026) Cabinet Médical MEURENS-GROSCH is active, legal situation “Normale toestand”, started on 23 March 2005.

Is Cabinet Médical MEURENS-GROSCH registered on Peppol?

Yes, Cabinet Médical MEURENS-GROSCH is registered on the Peppol network with ID 0208:0872680789.

What is the enterprise number of Cabinet Médical MEURENS-GROSCH?

The enterprise number of Cabinet Médical MEURENS-GROSCH is BE0872680789.

When was Cabinet Médical MEURENS-GROSCH founded?

Cabinet Médical MEURENS-GROSCH was founded on 23 March 2005.

Who are the directors of Cabinet Médical MEURENS-GROSCH?

According to the 2025 annual accounts, the directors of Cabinet Médical MEURENS-GROSCH are: Stéphanie GROSCH, Bernard MEURENS.

Is Cabinet Médical MEURENS-GROSCH a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 March 2005; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Cabinet Médical MEURENS-GROSCH make in 2025?

Cabinet Médical MEURENS-GROSCH posted a profit after taxes of € 49,490 in financial year 2025.

What is the revenue of Cabinet Médical MEURENS-GROSCH?

As a small company, Cabinet Médical MEURENS-GROSCH is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 113,996.

Cabinet Médical MEURENS-GROSCH (Private Limited) - Olne

Dossier Cabinet Médical MEURENS-GROSCH, printed on 30 September 2026 from databakkes.be/en/0872680789/cabinet-medical-meurens-grosch. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Cabinet Médical MEURENS-GROSCH from Olne, company number BE0872680789, closed financial year 2025 with a result of € 49,490 after tax. For that financial year Cabinet Médical MEURENS-GROSCH recorded a gross margin of € 113,996 and equity of € 271,113. Compared with financial year 2024, the result moved from € 89,908 to € 49,490. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 25, 2026.

What it is worth Healthy

€ 271,113

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 49,490

▼ 45% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 85,419

▼ 5% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 55,750 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 50,739

▼ 55% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 45,719

▼ 48% vs 2024

€ 28,712 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 2,684

▼ 64% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 14,802

▼ 40% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 111,115 Gross margin 2022: € 111,115 First fiscal year in the series	€ 109,965 Gross margin 2023: € 109,965 ▼ 1% vs 2022 (€ 111,115) Unfavourable step	€ 176,052 Gross margin 2024: € 176,052 ▲ 60% vs 2023 (€ 109,965) Favourable step	€ 113,996 Gross margin 2025: € 113,996 ▼ 35% vs 2024 (€ 176,052) Unfavourable step	▼ 35%
Profit after taxes	€ 63,885 Profit after taxes 2022: € 63,885 First fiscal year in the series	€ 71,825 Profit after taxes 2023: € 71,825 ▲ 12% vs 2022 (€ 63,885) Favourable step	€ 89,908 Profit after taxes 2024: € 89,908 ▲ 25% vs 2023 (€ 71,825) Favourable step	€ 49,490 Profit after taxes 2025: € 49,490 ▼ 45% vs 2024 (€ 89,908) Unfavourable step	▼ 45%
Equity	€ 170,640 Equity 2022: € 170,640 First fiscal year in the series	€ 202,465 Equity 2023: € 202,465 ▲ 19% vs 2022 (€ 170,640) Favourable step	€ 277,373 Equity 2024: € 277,373 ▲ 37% vs 2023 (€ 202,465) Favourable step	€ 271,113 Equity 2025: € 271,113 ▼ 2% vs 2024 (€ 277,373) Unfavourable step	▼ 2%
Total debts	€ 178,192 Total debts 2022: € 178,192 First fiscal year in the series	€ 107,925 Total debts 2023: € 107,925 ▼ 39% vs 2022 (€ 178,192) Favourable step	€ 125,503 Total debts 2024: € 125,503 ▲ 16% vs 2023 (€ 107,925) Unfavourable step	€ 80,628 Total debts 2025: € 80,628 ▼ 36% vs 2024 (€ 125,503) Favourable step	▼ 36%
Cash	€ 93,200 Cash 2022: € 93,200 First fiscal year in the series	€ 72,644 Cash 2023: € 72,644 ▼ 22% vs 2022 (€ 93,200) Unfavourable step	€ 89,649 Cash 2024: € 89,649 ▲ 23% vs 2023 (€ 72,644) Favourable step	€ 85,419 Cash 2025: € 85,419 ▼ 5% vs 2024 (€ 89,649) Unfavourable step	▼ 5%
Retained profit	€ 162,580 Retained profit 2022: € 162,580 First fiscal year in the series	€ 194,405 Retained profit 2023: € 194,405 ▲ 20% vs 2022 (€ 162,580) Favourable step	€ 269,313 Retained profit 2024: € 269,313 ▲ 39% vs 2023 (€ 194,405) Favourable step	€ 263,053 Retained profit 2025: € 263,053 ▼ 2% vs 2024 (€ 269,313) Unfavourable step	▼ 2%
Dividend	€ 72,000 Dividend 2022: € 72,000 First fiscal year in the series	€ 40,000 Dividend 2023: € 40,000 ▼ 44% vs 2022 (€ 72,000) Unchanged	€ 15,000 Dividend 2024: € 15,000 ▼ 62% vs 2023 (€ 40,000) Unchanged	€ 55,750 Dividend 2025: € 55,750 ▲ 272% vs 2024 (€ 15,000) Unchanged	▲ 272%
Bank debt	€ 86,688 Bank debt 2022: € 86,688 First fiscal year in the series	€ 85,810 Bank debt 2023: € 85,810 ▼ 1% vs 2022 (€ 86,688) Favourable step	€ 88,386 Bank debt 2024: € 88,386 ▲ 3% vs 2023 (€ 85,810) Unfavourable step	€ 45,719 Bank debt 2025: € 45,719 ▼ 48% vs 2024 (€ 88,386) Favourable step	▼ 48%
Balance sheet total	€ 348,832 Balance sheet total 2022: € 348,832 First fiscal year in the series	€ 310,390 Balance sheet total 2023: € 310,390 ▼ 11% vs 2022 (€ 348,832) Unchanged	€ 402,876 Balance sheet total 2024: € 402,876 ▲ 30% vs 2023 (€ 310,390) Unchanged	€ 351,741 Balance sheet total 2025: € 351,741 ▼ 13% vs 2024 (€ 402,876) Unchanged	▼ 13%

Key figures of Cabinet Médical MEURENS-GROSCH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Cabinet Médical MEURENS-GROSCH?

What happened at Cabinet Médical MEURENS-GROSCH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 25, 2026 New annual accounts for financial year 2025: profit of € 49,490 (▼ 45% vs 2024). filed late Source: NBB ↗
Mar 23, 2005 Start of the company according to the CBE. KBO
2005 Stéphanie GROSCH became a director. NBB
2005 Bernard MEURENS became a director. NBB

In short

From € 63,885 profit in 2022 to € 49,490 profit in 2025.

Paid € 121,501 in corporate taxes since 2022.

Best year ever: 2024, with € 89,908 profit.

Paid out € 182,750 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Cabinet Médical MEURENS-GROSCH? We notify you, reason included.

Follow Cabinet Médical MEURENS-GROSCH

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit